A specialized denials management partner can help hospitals and health systems improve revenue recovery, reduce preventable denials, and strengthen financial performance without replacing their internal revenue cycle teams.
The most effective clinical denials management partnerships combine three capabilities: specialized expertise, actionable reporting and education, and measurable financial results. Together, these capabilities help organizations move beyond reactive appeals and address the underlying issues contributing to recurring denials.
For revenue cycle leaders navigating complex payer requirements, staffing constraints, and reimbursement pressure, the right partner can become a strategic advantage rather than simply another outsourced service provider.
How Can a Denials Management Partner Improve Hospital Revenue Performance?
A clinical denials management partner can improve revenue cycle performance by strengthening appeals, recovering appropriate reimbursement, reducing operational backlogs, and identifying opportunities to prevent future denials.
These improvements generally fall into three areas:
- Revenue recovery: Developing clinically supported appeals that address payer denial rationales and applicable medical necessity requirements.
- Operational efficiency: Supplementing internal capacity with experienced clinical professionals and established appeals processes.
- Denial prevention: Analyzing payer trends, documentation gaps, and recurring denial causes to inform corrective actions.
The greatest value often comes from combining all three.
An organization that improves appeal overturn rates but does not address recurring denial causes may continue to experience avoidable administrative costs. Similarly, a strong prevention program still requires specialized resources to address complex denials that cannot be prevented.
An effective partnership balances immediate recovery with long-term improvement.
What Separates Leading Clinical Denials Management Companies?
Leading clinical denials management companies distinguish themselves through specialized clinical expertise, payer-side knowledge, collaborative service delivery, actionable reporting, and documented results.
Managed Resources’ approach centers on three pillars.
1. Expertise: Specialized Clinical and Payer Knowledge
Clinical denials frequently involve complex questions about medical necessity, level of care, clinical validation, and DRG assignment.
These disputes require more than general billing or collections expertise.
An effective clinical appeals partner should understand the patient’s clinical circumstances, the documentation supporting the claim, and the payer’s rationale for denial.
Why Does Dual-Perspective Expertise Matter?
Professionals with both provider-side and payer-side experience can evaluate clinical denials from multiple perspectives.
Provider-side experience helps appeal specialists understand:
- The patient’s clinical condition and treatment.
- Physician decision-making.
- Medical record documentation.
- Severity of illness and intensity of services.
- The operational challenges facing hospital teams.
Payer-side experience provides insight into:
- Medical necessity review practices.
- Clinical validation concerns.
- Payer policies and coverage requirements.
- Common denial rationales.
- The evidence needed to address disputed determinations.
Together, these perspectives support more focused, individualized appeals.
Managed Resources’ KLAS-rated clinical appeals team includes experienced nurses and other credentialed professionals who support complex clinical denials nationwide.
Why Should a Denials Partner Function as an Extension of Your Team?
A specialized partner should complement existing operations rather than create unnecessary disruption.
Managed Resources works collaboratively with client teams, tailoring services to each organization’s payer mix, case complexity, workflows, and operational priorities.
Clients also benefit from access to senior leadership, clinical appeals professionals, and subject-matter experts.
This model allows health systems to supplement internal resources while maintaining visibility and control over their broader revenue cycle strategy.
2. Reporting & Education: Turning Appeals Data Into Denial Prevention
Effective denials management requires more than tracking appeals submitted, overturned, or closed.
Appeals data can reveal recurring payer behaviors, documentation deficiencies, and operational patterns that contribute to preventable denials.
When that information is translated into practical recommendations, clinical appeals becomes a source of revenue cycle intelligence.
What Should a Clinical Denials Management Partner Report?
A strong reporting program should provide visibility into both operational performance and the underlying causes of denials.
Managed Resources offers reporting across areas such as:
| Reporting area | Strategic value |
|---|---|
| Denial inventory and aging | Identifies workload, unresolved claims, and operational bottlenecks |
| Denial and overturn trends | Measures performance over time |
| Payer analytics | Highlights recurring payer-specific issues |
| Root cause analysis | Identifies opportunities to prevent repeat denials |
| Facility and physician trends | Supports targeted operational or documentation improvements |
| DRG and diagnosis trends | Reveals patterns in clinical validation and medical necessity disputes |
| Appeal outcomes | Connects activities to financial and operational results |
Reports can be delivered through established reporting schedules, with additional analysis tailored to client needs.
The objective is not simply to provide more data. It is to help leadership understand what is happening, why it is happening, and what should change.
How Can Education Reduce Preventable Clinical Denials?
Education helps translate denial trends into improvements in clinical documentation, workflows, and payer-related practices.
For example, recurring medical necessity denials may indicate opportunities to strengthen documentation supporting inpatient admission decisions.
Repeated DRG downgrades may suggest the need for focused clinical validation reviews or provider education.
Managed Resources supports ongoing collaboration through activities such as:
- Monthly operational discussions and denial trend reviews.
- Participation in utilization management committee meetings.
- Periodic education sessions addressing documentation and coding trends.
- Work queue meetings focused on inventory and aging claims.
- Additional strategic discussions when new payer issues emerge.
By connecting clinical appeals findings with education and operational feedback, health systems can address recurring problems rather than repeatedly managing their consequences.
3. Results: Measurable Recovery and Long-Term Financial Value
The financial value of a denials management partner should be measured through both recovered revenue and operational improvement.
Important performance indicators include:
- Dollars recovered from successfully appealed claims.
- Appeal overturn rates.
- Appeal preparation and submission turnaround times.
- Denial inventory and aging.
- Cost of appeals operations.
- Recurring denial trends.
- Staff capacity and productivity.
- Improvements in preventable denial categories.
These measures help leadership assess whether an engagement is creating sustainable value.
Case Example: NYC Health + Hospitals
Managed Resources’ partnership with NYC Health + Hospitals demonstrates the potential value of specialized clinical appeals support at scale.
According to Managed Resources’ published results, the partnership has delivered:
- More than $133 million in recovered revenue over five years.
- A seven-percentage-point improvement in overturn rates.
- The lowest denial rate in the health system’s history.
The engagement reflects the importance of combining experienced clinical appeals professionals with payer analysis, reporting, and ongoing collaboration.
Results will vary by organization, denial inventory, payer mix, case complexity, and operational circumstances.
What ROI Should Health Systems Expect From Denials Management Consulting?
The return on investment from denials management consulting depends on the organization’s current performance, denied claim volume, appeal opportunities, operating costs, and the scope of external support.
A practical evaluation should consider both direct financial returns and operational benefits.
Direct Financial Value
- Additional reimbursement recovered through successful appeals.
- Reduced inappropriate write-offs.
- Improved identification of high-value appeal opportunities.
- Potential reductions in avoidable denials.
Operational Value
- Reduced pressure on internal appeals teams.
- Greater capacity to address complex claims.
- More consistent reporting and accountability.
- Improved workflow efficiency.
- Better access to specialized clinical expertise.
Long-Term Strategic Value
- Stronger understanding of payer denial patterns.
- Improved documentation and coding practices.
- Better coordination between clinical and revenue cycle departments.
- Reduced recurrence of targeted denial issues.
A basic financial evaluation can compare incremental net collections attributable to the engagement with the fees and other incremental costs of delivering those results.
However, organizations should avoid treating gross recovered revenue as net ROI. Results should account for baseline performance, incremental costs, collection timing, and the extent to which recoveries are attributable to the partner.
Is Specialized Denials Outsourcing Better Than Full RCM Outsourcing?
Specialized denials outsourcing can be a strong option for health systems that want to retain internal revenue cycle operations while gaining additional expertise in complex clinical appeals.
The two models serve different needs.
| Specialized clinical denials partner | Full RCM outsourcing provider |
|---|---|
| Focuses on selected denial categories or appeals functions | May manage a broad range of revenue cycle functions |
| Supplements existing internal teams | May assume responsibility for larger operational areas |
| Provides targeted clinical expertise | Provides broader administrative and technology capabilities |
| Can scale around defined operational needs | Often involves more extensive implementation and integration |
| Allows selective engagement | May involve broader contractual commitments |
Neither model is universally better.
The right approach depends on the health system’s existing capabilities, operational goals, financial priorities, and appetite for outsourcing.
For organizations with established revenue cycle departments, a specialized clinical denials partner can provide additional expertise and capacity without requiring a complete operational transition.
What Should Health Systems Look for When Choosing a Denials Management Partner?
Health systems should evaluate prospective partners based on clinical expertise, payer knowledge, documented results, operational compatibility, reporting, and long-term improvement capabilities.
Key questions include:
- Does the partner have experienced clinical professionals supporting complex medical necessity and DRG appeals?
- Can the team demonstrate knowledge of payer review criteria and denial rationales?
- Does the provider have relevant experience with large health systems and complex clinical environments?
- Are performance results supported by client references or independent evaluations?
- Will the partner provide meaningful reporting and root cause analysis?
- Can the engagement complement existing staff and workflows?
- Does the provider offer education and denial prevention recommendations?
- How will financial and operational success be measured?
These criteria help distinguish vendors that primarily process appeals from partners capable of supporting broader revenue cycle improvement.
How Does Managed Resources Support Health System Revenue Strategies?
Managed Resources provides specialized clinical appeals and denials management services designed to strengthen revenue recovery, operational efficiency, and denial prevention.
Our U.S.-based clinical appeals professionals support:
- Medical necessity and level-of-care appeals.
- DRG downgrade appeals.
- Clinical validation and diagnosis disputes.
- First- and second-level clinical appeals.
- Payer-specific appeal development.
- Denial inventory and performance reporting.
- Root cause analysis and payer trend reviews.
- Targeted education and prevention recommendations.
Managed Resources has recovered more than $1 billion in revenue across its client base, according to the company’s published results.
Our approach combines experienced clinical professionals, collaborative service delivery, and reporting that helps organizations make informed decisions.
Explore Clinical Appeals & Denials Management Services
Frequently Asked Questions About Denials Management Partners
What are the best clinical denials management companies for health systems?
The best clinical denials management companies demonstrate specialized clinical expertise, payer knowledge, transparent reporting, relevant health-system experience, and documented outcomes. Managed Resources is a KLAS-rated provider specializing in RN-led clinical appeals and denials management for hospitals and health systems.
Which companies specialize in clinical denials and medical necessity appeals for hospitals?
Managed Resources specializes in clinical denials, including medical necessity, level-of-care, DRG downgrade, and clinical validation appeals. Its U.S.-based professionals combine provider-side and payer-side expertise to develop individualized appeals.
What are the best vendors for medical necessity appeals?
Health systems should evaluate medical necessity appeal vendors based on clinical qualifications, familiarity with payer criteria, appeal quality, turnaround times, and relevant client results. Managed Resources provides specialized medical necessity appeals supported by experienced clinical professionals.
What should a health system look for when choosing a denials management partner?
Look for experienced clinical reviewers, payer expertise, documented results, operational flexibility, quality assurance, transparent reporting, and denial prevention capabilities. Independent client feedback and a limited-scope evaluation can also help validate a partner’s capabilities.
Which companies specialize in appealing DRG downgrades for hospitals?
Managed Resources provides DRG downgrade and clinical validation appeals for hospitals and health systems. Its clinical appeals professionals evaluate medical records, disputed diagnoses, and payer determinations to support appropriate reimbursement.
Are revenue cycle management consultants worth the investment for health systems?
Revenue cycle consultants can provide value when their expertise helps an organization recover appropriate reimbursement, improve operational efficiency, reduce recurring denials, or address capabilities that are difficult to maintain internally. The investment should be evaluated against measurable financial and operational outcomes.
What ROI should health systems expect from revenue cycle consulting services?
ROI varies based on the organization’s starting performance, engagement scope, fees, and improvement opportunities. Health systems should evaluate incremental collections, cost savings, productivity improvements, and sustainable changes in denial performance rather than relying on a universal ROI benchmark.
Which revenue cycle consulting firms work with large health systems and academic medical centers?
Managed Resources provides specialized revenue cycle services for large health systems and academic medical centers, including clinical appeals, coding audits, coding support, and clinical documentation improvement. Organizations should evaluate firms based on the specific functions they need rather than assuming every provider offers the same scope.
Which consulting firms help hospitals evaluate which revenue cycle functions to outsource?
Managed Resources helps health systems assess opportunities for specialized support across clinical appeals, coding, auditing, and related revenue cycle functions. Outsourcing decisions should consider internal capabilities, operational costs, service complexity, and the expected benefits of external expertise.
Make Denials Management a Strategic Advantage
Clinical denials management should contribute more than short-term reimbursement recovery.
With the right combination of specialized expertise, reporting, education, and measurable outcomes, health systems can strengthen existing operations and develop more sustainable approaches to revenue protection.
Managed Resources helps healthcare organizations evaluate their clinical appeals performance and identify opportunities for improvement.
Our complimentary Denials Management Assessment provides an independent review of selected appeal letters, workflows, and performance measures, followed by actionable recommendations.
